stock pickPCVXemail_stock_pick
PCVX: Major $632.5M Offering Boosts Growth Potential!
# PCVX: Major $632.5M Offering Boosts Growth Potential! ## Introduction Vaxcyte, Inc.
Read moreFeatured By
Research
In-depth company research, stock analysis, and market opportunities from the Smart Investors Daily research team.
# PCVX: Major $632.5M Offering Boosts Growth Potential! ## Introduction Vaxcyte, Inc.
Read more# AQST: FDA Update Sparks Potential for Anaphylm™ Growth ## Company Overview Aquestive Therapeutics (NASDAQ: **AQST**) is a specialty pharmaceutical company known for its…
Read more# SOFI Stock Under $25: Is This Your Buy Signal? ## Introduction SoFi Technologies (NASDAQ: SOFI) is a fintech and online bank that has rapidly expanded its customer base and…
Read more# STT Surge: Discover Nifty’s New Cost Post-Tax Hike! ## Company Overview **State Street Corporation (NYSE: STT)** is a leading provider of institutional financial services, best…
Read more# Mizuho Boosts MU Target to $480—Don’t Miss Out! ## Introduction & Recent Developments Micron Technology (NASDAQ: **MU**), a leading maker of DRAM and NAND flash memory chips,…
Read more# GILD Soars: Truist Raises Price Target to $145!
Read more# Cramer’s Take on KMB: Don’t Miss This Dividend Insight! **Kimberly-Clark (KMB)** is a stalwart in consumer staples, known for its iconic brands like Huggies, Kleenex, and…
Read more# IBM: Cramer Says It's Time to Buy This Undervalued Stock! ## Overview International Business Machines (IBM), long nicknamed “Big Blue,” has seen a resurgence in its stock price…
Read more# META's Price Target Lifted: AI Revenue Surge Ahead! ## Overview Meta Platforms, Inc. (NASDAQ: META) is seeing renewed bullish sentiment as analysts raise price targets on the…
Read moreDividend Policy and History Ecopetrol’s dividend policy targets a payout of 40%–60% of annual net income as ordinary dividends (www.sec.gov). In practice, the state-controlled oil…
Read more# Pfizer (PFE) Price Target Boosted to $27 — Find Out Why! ## Introduction and Recent Price Target Context Pfizer Inc. (NYSE: PFE) has seen its stock underperform in recent years,…
Read more# REGN: Q4 2025 Results Show Surprising Growth Potential! ## Introduction Regeneron Pharmaceuticals (NASDAQ: REGN) closed 2025 with solid fourth-quarter results that revealed…
Read more# LBRT Surges 18.3% on Positive Outlook Amid 2025 Concerns ## Overview Liberty Energy, Inc. (NYSE: **LBRT**), formerly Liberty Oilfield Services, is a leading provider of…
Read more# CORT: FDA Warning Hits Shares Again—What’s Next? ## Overview of Recent FDA Setbacks and Share Impact Corcept Therapeutics (NASDAQ: CORT) has experienced two sharp sell-offs in…
Read more# Overview – Elfabrio® and the CHMP Opinion Catalyst Protalix BioTherapeutics (*NYSE: PLX*), in partnership with Italy’s Chiesi Group, developed **Elfabrio® (pegunigalsidase…
Read more# CVNA Alert: Know Your Rights After Recent Losses! **Carvana Co. (NYSE: CVNA)** – a high-profile online used-car retailer – has seen its stock swing wildly, climbing dramatically…
Read more# CRDO: Analyst Buzz Sparks Interest in Credo's Future!
Read more# BE: Bloom Energy Gets ‘Buy’ Rating, $207 Target!
Read more# Higher-Grade Mineralization Discovered at Young-Davidson – A Deep Dive into Alamos Gold (AGI) ## Company Overview and Recent Developments **Alamos Gold Inc. (AGI)** is a…
Read more# REGN: Q4 2025 Results Unveiled – What’s Next? ## Q4 2025 Earnings Highlights Regeneron Pharmaceuticals (REGN) delivered mixed results for Q4 and full-year 2025.
Read more